PREliminary Safety Evaluation of Nanoporous Tacrolimus eluting stents - PRESENT
Trial designed to test a tracrolimus-eluting stent in coronary arteries.
Patients Enrolled: 60
Death, MI, TVR
30 patients received a ceramic-coated stent and 30 received a ceramic-coated stent including 60 mcg tacrolimus. Follow-up is scheduled at 14 days, 6 months, and 12 months.
Two patients receiving the drug-coated stent experienced adverse coronary events (unstable angina), one after 67 days and a second after 59 days.
Final results are pending as are angiographic and late clinical follow-up.
Keywords: Follow-Up Studies, Ceramics, Coronary Restenosis, Drug-Eluting Stents, Coronary Vessels, Sirolimus, Tacrolimus
< Back to Listings